GSK PLC SP. ADR/2 NEW (GS70) — Cash Flow Reinvestment Rate
GSK PLC SP. ADR/2 NEW (GS70) has a Cash Flow Reinvestment Rate of 0.40x as of March 2026, reinvesting €452.00 Million (capex €443.00 Million plus investments €9.00 Million) from operating cash flow of €1.14 Billion. Check GS70 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GSK PLC SP. ADR/2 NEW Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for GSK PLC SP. ADR/2 NEW across 5 annual periods. Explore GS70 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for GSK PLC SP. ADR/2 NEW (2021–2025)
Year-by-year capital reinvestment analysis for GSK PLC SP. ADR/2 NEW. For live market cap and broader valuation context, see GSK PLC SP. ADR/2 NEW (GS70) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | €3.00 Billion | €7.74 Billion | €2.98 Billion | ▼ -15.5% |
| 2024 | 0.46x | €3.00 Billion | €6.55 Billion | €2.98 Billion | ▲ +28.4% |
| 2023 | 0.36x | €2.42 Billion | €6.77 Billion | €2.34 Billion | ▲ +17.0% |
| 2022 | 0.31x | €2.26 Billion | €7.40 Billion | €2.26 Billion | ▼ -9.2% |
| 2021 | 0.34x | €2.67 Billion | €7.95 Billion | €2.65 Billion | — |